AI-Driven Enzyme Engineering
Built for Translation

Medvolt engineers therapeutic and industrial enzymes using integrated AI and physics-based simulations to enhance activity, selectivity, stability and developability while reducing experimental iterations

Why Enzyme Engineering Needs an AI-Driven Approach

Moving beyond trial-and-error toward structure-based, AI-driven enzyme design

Explore Vast Enzyme Design Space

Rational exploration of large mutational landscapes using structure-based modeling and protein engineering workflows.

De-risk Early

Instantly filter unstable, immunogenic, or non-selective enzyme variants using AI-guided screening before laboratory validation.

Rapid Optimization

Accelerate enzyme optimization through multi-objective scoring of activity, selectivity and stability using computational simulations.

Lab-Ready Results

Translate in silico enzyme design into experimental validation with physics-based simulations and predictive confidence.

Medvolt’s Advanced Enzyme Engineering Capabilities

Computational enzyme design from variant generation to physics-based validation

AI-Guided Variant Design

Generative AI models conditioned on enzyme structure and substrate context to optimize catalytic activity, regioselectivity and substrate specificity.

Structure-First Modeling

High-fidelity 3D enzyme and protein models preserving catalytic geometry and metal coordination, even in the absence of co-crystal structures.

Mechanism-Aware Optimization

Structure-based mutagenesis guided by enzyme-substrate interaction analysis to optimize reaction mechanisms, kinetics and regioselectivity.

Stability & Developability

Computational screening for thermal stability, folding robustness and aggregation propensity ensures downstream formulation and expression compatibility.

Immunogenicity & Safety

Early immunogenicity prediction and epitope mapping to minimize T-cell hotspots and protease-sensitive regions through targeted sequence optimization.

Physics-Based Validation

Docking, molecular dynamics simulations and free energy calculations validate enzyme-substrate binding stability, selectivity and dynamic behavior before laboratory testing.

Closed-Loop AI–Experimental
Enzyme Engineering Workflow

Medvolt’s enzyme engineering workflow integrates computational design and experimental validation into a continuous learning system

01

Define Objective

Target function, substrate specificity, reaction constraints and therapeutic or industrial application context

02

Sequence and Structure Intelligence

Homolog curation, multiple sequence alignment, structural modeling and conserved catalytic motif analysis

03

AI-Driven Design

Generative structure and sequence design guided by catalytic geometry, stability constraints and enzyme-substrate interactions

04

Multi-Parameter AI Scoring

Multi-objective scoring of catalytic activity, substrate selectivity, stability, immunogenicity and developability

05

Physics-Based Validation

Docking, molecular dynamics simulations and free energy calculations to validate binding stability and dynamic behavior

06

Experimental Handoff

Shortlisted enzyme variants delivered with structural models, binding analysis and mechanistic rationale for laboratory testing

07

Feedback and Model Refinement

Experimental kinetic and stability data reintegrated to retrain machine learning models and refine future enzyme design cycles

This closed-loop enzyme engineering approach reduces uncertainty, accelerates variant convergence, and continuously improves predictive accuracy through AI-driven learning

Enzyme Engineering Application Areas

Delivering therapeutic and industrial enzyme innovation through precision, structure-guided engineering

Therapeutic Enzymes
01

Therapeutic Enzymes

  • Oncology-focused therapeutic metabolic enzymes

  • Enzyme mimetics and mini-protein therapeutic scaffolds

  • Reduced immunogenicity and off-target toxicity

  • Enhanced half-life, stability & protease resistance

Biocatalysis and Green Chemistry
02

Biocatalysis and Green Chemistry

  • Regioselective and substrate-specific biocatalysts

  • Metal-dependent and industrial enzyme families

  • Yield optimization and metabolic pathway control

  • Enzyme repurposing and scaffold diversification

Enzyme Optimization and Redesign
03

Enzyme Optimization and Redesign

  • Catalytic activity and substrate specificity tuning

  • Stability enhancement under industrial or therapeutic conditions

  • Structure-based rational mutagenesis planning

  • Structure-guided enzyme repurposing and redesign

What Differentiates Medvolt in Enzyme Engineering

01

Integrated AI + physics platform

A unified enzyme engineering platform integrating deep learning, molecular simulations, and computational chemistry

02

Structure- and mechanism-aware design

Every enzyme variant recommendation is grounded in 3D structure, catalytic geometry, and reaction mechanism

03

Explicit handling of developability

Immunogenicity prediction, stability optimization, and formulation compatibility integrated from the first computational design cycle

04

Closed-loop AI–experimental philosophy

Each experimental dataset retrains machine learning models, strengthening predictive accuracy across enzyme design cycles

05

Scalable across enzyme classes

Scalable across diverse enzyme classes, from serine proteases and metalloproteases to NAD-dependent and metal-dependent enzymes

06

Human expertise at every stage

AI-accelerated computational enzyme engineering guided by domain expertise at every decision stage

We do not simply generate enzyme variants. We deliver validated, high-confidence design decisions.

Collaboration Models for AI-Driven Enzyme Engineering

Flexible partnership structures for computational enzyme engineering, from rapid variant design to strategic co-development

Built around your roadmap

Choose the engagement model that aligns with your scientific objectives, development timelines and internal R&D capabilities

Whether you are exploring a new enzyme class, de-risking a therapeutic enzyme candidate, or scaling a portfolio of biocatalyst programs, Medvolt integrates as a computational design engine, platform partner, or co-development team.

Partnership horizonProject-based engagements to multi-year enzyme engineering programs
Integration levelAPI-integrated enzyme design engine to fully embedded joint discovery teams
Model 01

Enzyme Design as a Service

Dedicated AI-driven enzyme engineering teams delivering optimized enzyme variants using structure-based modeling, molecular simulations and machine learning scoring.

  • Best for targeted, outcome-driven enzyme optimization projects

  • Access to Medvolt AI + molecular simulation stack

  • Ideal for teams with in-house experimental validation

Model 02

Strategic Planned Co-Development

Jointly executed enzyme engineering programs combining generative design, computational screening, simulations and iterative experimental feedback.

  • Shared roadmap and scientific governance

  • Integrated data infrastructure and closed-loop model refinement

  • Suited for therapeutic enzyme and platform-scale programs

Model 03

Platform & Discovery Partnerships

Long-term enzyme engineering partnerships where Medvolt becomes the computational backbone across portfolios, indications or industrial pipelines.

  • Continuous AI-driven optimization across programs

  • Flexible commercial structures including FTE, success-based or hybrid

  • Best for organizations scaling global enzyme innovation

Not sure which model fits best?

We design customized AI-driven enzyme engineering collaborations aligned to your scientific risk, infrastructure and portfolio strategy.

Why Medvolt

Accelerate Discovery

Medvolt's AI-powered platform cuts pre-clinical discovery time by 3x, reduces costs by 15x and lowers failure risk by 25%. Enhance your R&D efficiency with our in silico tools.

High-Throughput Data

Enrich your research with Medvolt's proprietary, gold-standard, high-throughput proprietary datasets. Our AI and NLP solutions deliver speed, precision and scalability.

Expert Collaboration

Our experienced, tech-driven team collaborates globally with leading pharma and biotech companies, ensuring impactful, scalable solutions.